RAPT THERAPTICS (RAPT) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 05/06/21
Do Options Traders Know Something About RAPT Therapeutics (RAPT) Stock We Don't?Zacks Investment Research • 04/12/21
RAPT Therapeutics to Report Promising Preclinical Studies Supporting its Pipeline of Immunotherapy Platforms at AACRGlobeNewsWire • 03/10/21
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/19/21
RAPT Therapeutics to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/23/20
RAPT Therapeutics Reports Positive Initial Data from Ongoing Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer IndicationsGlobeNewsWire • 11/16/20
RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer IndicationsGlobeNewsWire • 11/15/20
RAPT Therapeutics to Present at the Stifel 2020 Virtual Healthcare ConferenceGlobeNewsWire • 11/13/20
RAPT Therapeutics to Present at the BMO 2020 Prescriptions for Success Healthcare ConferenceGlobeNewsWire • 06/17/20
RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific ProgramGlobeNewsWire • 05/29/20
RAPT Therapeutics Highlights Early Results for RPT193 at Society for Investigative Dermatology MeetingGlobeNewsWire • 05/15/20